Omkar Speciality Chemicals Ltd. (NSE: OMKARCHEM) is a Thane, Maharashtra-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹7 Cr, it ranks #5,222 by market cap among the 6,137 Indian listed companies on FinBizNet, and #13 of 13 in Custom Synthesis and Specialty CDMO. At ₹3.41 (as of 25 Oct 2026), the share price is 46.3% below its 52-week high of ₹6.35 and 1.8% above its 52-week low of ₹3.35. The share price is down 37.3% over one year and up 0.0% over three months.
| Current Price | ₹3.41 |
|---|---|
| Market Cap | ₹7 Cr |
| NSE Symbol | OMKARCHEM |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | -4.4 |
| Return on Equity | 7.65% |
| Return on Assets | -2.12% |
| 52-Week Range | ₹3.35 – ₹6.35 |
| 1-Year Price Change | -37.3% |
| 3-Month Price Change | 0.0% |
| Beta (1Y) | 0.46 |
| Dividend Yield | 0.00% |
| Headquarters | Thane, Maharashtra |
| Website | www.omkarchemicals.com |
| Revenue | ₹0 Cr |
|---|---|
| Net Profit | ₹-0 Cr |
| EPS (Basic) | ₹-0.18 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Omkar Speciality Chemicals Limited manufactures and sells specialty chemicals and intermediates for chemical and allied industries in India and internationally. It provides a range of organic, inorganic, and organo inorganic intermediates. The company offers selenium derivatives, iodine derivatives, resolving agents, and advance intermediates, as well as tartaric acid derivatives and other intermediates. Its products have applications in the pharmaceuticals, neutraceuticals, fragrances and flavours, foods, poultry and veterinary, glass and ceramics, and electro plating segments. The company also exports its products to Europe, Canada, Asia, South America, and Australia. Omkar Speciality Chemicals Limited was incorporated in 1983 and is based in Thane, India.
1. Manufacturing and Sale of Chemicals-This segment researches, develops, manufactures, and sells specialty chemicals, human and veterinary bulk drugs, and pharma intermediates, as well as inorganic molecules having applications as feed ingredients, micro nutrients, etc.
1. Manufacturing and Sale of Speciality Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,389 Cr | 73.6 | 5.76% | ₹655 Cr | -2.2% |
| Neogen Chemicals Limited (Neogen) | ₹7,465 Cr | 227.6 | 3.58% | ₹250 Cr | +45.2% |
| Laxmi Organic Industries Ltd | ₹4,963 Cr | 59.9 | 4.08% | ₹968 Cr | -27.6% |
| Tatva Chintan Pharma Chem Ltd | ₹4,547 Cr | 105.8 | 5.53% | ₹217 Cr | +22.0% |
| Prasol Chemicals Limited | ₹4,476 Cr | 50.7 | — | ₹434 Cr | — |
| Paushak Ltd. | ₹2,046 Cr | 42.9 | 8.22% | ₹84 Cr | — |
| Sunshield Chemicals Ltd. | ₹906 Cr | 27.7 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹803 Cr | 33.4 | 4.80% | ₹65 Cr | -27.6% |
| Omkar Speciality Chemicals Ltd. | ₹7 Cr | -4.4 | 7.65% | ₹0 Cr | -37.3% |
Listed by market capitalisation. Ratios are shown for context only.
Omkar Speciality Chemicals Ltd. is trading at ₹3.41, with a market capitalisation of ₹7 Cr.
Omkar Speciality Chemicals Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Omkar Speciality Chemicals Ltd. has a P/E of -4.4 and a return on equity of 7.65%.
Omkar Speciality Chemicals Ltd. is listed on the NSE under the symbol OMKARCHEM.
Omkar Speciality Chemicals Ltd.'s share price is down 37.3% over one year and up 0.0% over three months. Its 52-week range is ₹3.35 to ₹6.35.
In Q1 FY27, Omkar Speciality Chemicals Ltd. reported revenue of ₹0 Cr and net profit of ₹-0 Cr, with basic EPS of ₹-0.18 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.